XIII Escuela Internacional de Salud Pública y Epidemiología

Past Events
Written By Susan Harris
Maha Tahiri, PhD, S2B presentation on GLP-1 medication impact in Latin America.

January 19, 2026

Maha Tahiri PhD

A keynote on how Latin America is responding to the rise of GLP-1 medications and their impact on obesity.

Susan Harris
Previous

February 2026: What post-GLP-1 eating means for food innovation
Next

Food ingredients (Fi) Europe 2025 – The Ozempic Effect